Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 4:47 PM
Ignite Modification Date:
2025-12-25 @ 2:33 PM
NCT ID:
NCT02119650
Group ID:
EG000
Title:
Double-Blind Treatment: Ruxolitinib + Pemetrexed/Cisplatin
Description:
Ruxolitinib was self-administered as a 15 mg BID oral treatment during the randomized, double-blind treatment, without regard to food. Pemetrexed 500 mg/m\^2 was administered as an intravenous infusion over 10 minutes, and 75 mg/m\^2 Cisplatin was infused over 2 hours beginning 30 ± 5 minutes after the end of the pemetrexed infusion on Day 1 of each 21-day cycle (Treatment Cycles).
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
19
Serious Number At Risk:
39
Other Number Affected:
37
Other Number At Risk:
39
Study:
NCT02119650
Results Section:
NCT02119650
Adverse Events Module:
NCT02119650